Management of Autism-Related Agitation
Evidence-Based First-Line Treatment
- The American Academy of Child and Adolescent Psychiatry recommends risperidone and aripiprazole as first-line pharmacological interventions for hyperactivity, impulsivity, agitation, temper outbursts, and aggression in children with Autism Spectrum Disorder (ASD) 1
- Risperidone has demonstrated efficacy in 69% of patients, with significant improvements in irritability and hyperactivity subscales, compared to 12% on placebo 1
- Aripiprazole has shown efficacy in 56% of patients at 5 mg, with significant improvements in irritability, hyperactivity, and stereotypy, compared to 35% on placebo 1
Quetiapine: Lack of Evidence in ASD
- There is no evidence from randomized controlled trials to support the use of quetiapine for autism-related agitation, according to the American Academy of Child and Adolescent Psychiatry 1
If Quetiapine Must Be Used (Off-Label)
- The American Academy of Pediatrics suggests that immediate-release formulation dosed TID may be preferable for quetiapine use in pediatric patients, due to its flexible dose titration, shorter onset of action, and ability to target specific time periods 2
- Close surveillance is mandatory when using quetiapine in pediatric patients, particularly those with a history of in utero cocaine exposure, due to the potential for behavioral activation, sedation, and cognitive effects 2
Practical Algorithm for Acute Agitation Management
- The American Academy of Pediatrics recommends a step-wise approach to managing acute agitation, starting with benzodiazepines (such as lorazepam) for rapid control, followed by antipsychotics (such as risperidone or aripiprazole) if a psychiatric etiology is confirmed 2
- A combination approach using antipsychotics and benzodiazepines may be more effective than either alone for severe agitation, according to the American Academy of Pediatrics 2